Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats

BACKGROUND Brain phospholipid metabolism and membrane fluidity may be involved in the pathophysiology of mood disorders. We showed previously that cytidine, which increases phospholipid synthesis, has antidepressant-like effects in the forced swim test (FST) in rats, a model used in depression research. Because cytidine and uridine both stimulate synthesis of cytidine 5'-diphosphocholine (CDP-choline, a critical substrate for phospholipid synthesis), we examined whether uridine would also produce antidepressant-like effects in rats. We also examined the effects of omega-3 fatty acids (OMG), which increase membrane fluidity and reportedly have antidepressant effects in humans, alone and in combination with uridine. METHODS We first examined the effects of uridine injections alone and dietary supplementation with OMG alone in the FST. We then combined sub-effective treatment regimens of uridine and OMG to determine whether these agents would be more effective if administered together. RESULTS Uridine dose-dependently reduced immobility in the FST, an antidepressant-like effect. Dietary supplementation with OMG reduced immobility when given for 30 days, but not for 3 or 10 days. A sub-effective dose of uridine reduced immobility in rats given sub-effective dietary supplementation with OMG. CONCLUSIONS Uridine and OMG each have antidepressant-like effects in rats. Less of each agent is required for effectiveness when the treatments are administered together.

[1]  L. Marangell,et al.  Omega‐3 fatty acids for the prevention of postpartum depression: Negative data from a preliminary, open‐label pilot study , 2004, Depression and anxiety.

[2]  P. Renshaw,et al.  Antidepressant-like effects of cytidine in the forced swim test in rats , 2002, Biological Psychiatry.

[3]  P F Renshaw,et al.  Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. , 1997, The American journal of psychiatry.

[4]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[5]  K. Yamauchi,et al.  Structural analysis of histamine N-methyltransferase gene. , 1995, Methods and findings in experimental and clinical pharmacology.

[6]  T. Nishizaki,et al.  A long-lasting facilitation of hippocampal neurotransmission via a phospholipase A2 signaling pathway. , 2001, Life sciences.

[7]  E. Nestler,et al.  Altered Responsiveness to Cocaine and Increased Immobility in the Forced Swim Test Associated with Elevated cAMP Response Element-Binding Protein Expression in Nucleus Accumbens , 2001, The Journal of Neuroscience.

[8]  E. Gould,et al.  Preclinical models: status of basic research in depression , 2002, Biological Psychiatry.

[9]  W. Clark,et al.  A randomized efficacy trial of citicoline in patients with acute ischemic stroke. , 1999, Stroke.

[10]  J. Hibbeln.  Fish consumption and major depression , 1998, The Lancet.

[11]  A. Stoll,et al.  Omega-3 fatty acids in major depression. , 2001, World review of nutrition and dietetics.

[12]  H. Meltzer,et al.  Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients , 1999, Psychiatry Research.

[13]  A. Stoll,et al.  Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. , 2000, Bipolar disorders.

[14]  A. Meli,et al.  Is the forced swimming test a suitable model for revealing antidepressant activity? , 2004, Psychopharmacology.

[15]  K. Honkalampi,et al.  Fish consumption, depression, and suicidality in a general population. , 2001, Archives of general psychiatry.

[16]  J. Coyle,et al.  Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments , 2003, Neuron.

[17]  N. Kato,et al.  Mitochondrial dysfunction in bipolar disorder. , 2000, Bipolar disorders.

[18]  J. Buttriss,et al.  The relationship between alpha-tocopherol and phospholipid fatty acids in rat liver subcellular membrane fractions. , 1988, Biochimica et biophysica acta.

[19]  R. Wurtman,et al.  Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells , 2003, Brain Research.

[20]  A. Sinclair,et al.  Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression , 2007, Lipids.

[21]  Y. Bersudsky,et al.  Lack of effect of eicosapentaenoic acid in the Porsolt forced swimming test model of depression , 2002, Acta Neuropsychiatrica.

[22]  A. Stoll,et al.  Omega-3 Fatty Acid Treatment and T2 Whole Brain Relaxation Times in Bipolar Disorder , 2004 .

[23]  M. Shinitzky,et al.  Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Wurtman,et al.  Evidence that 5′‐Cytidinediphosphocholine Can Affect Brain Phospholipid Composition by Increasing Choline and Cytidine Plasma Levels , 1995, Journal of neurochemistry.

[25]  P. Renshaw,et al.  Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report , 1999, Psychopharmacology.

[26]  D. Braus,et al.  The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. , 2000, Archives of general psychiatry.

[27]  P. Renshaw,et al.  Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy , 2000, Biological Psychiatry.

[28]  F E Preston,et al.  The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. , 1985, Atherosclerosis.

[29]  P. Renshaw,et al.  Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study , 2002, Psychopharmacology.

[30]  David T George,et al.  Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics , 1998, Biological Psychiatry.

[31]  D. Horrobin,et al.  Depletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients , 1998, Biological Psychiatry.

[32]  S. Knapp,et al.  Enhancement of free fatty acid incorporation into phospholipids by choline plus cytidine , 1999, Brain Research.

[33]  R. Wurtman,et al.  Effect of oral CDP-choline on plasma choline and uridine levels in humans. , 2000, Biochemical pharmacology.

[34]  P. Willner,et al.  The validity of animal models of depression , 2004, Psychopharmacology.

[35]  D. Horrobin,et al.  A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. , 2002, Archives of general psychiatry.

[36]  C. Meier,et al.  Hypothyroidism and thyroxin substitution affect the n−3 fatty acid composition of rat liver mitochondria , 1991, Lipids.

[37]  J. Exton.  Cell signalling through guanine-nucleotide-binding regulatory proteins (G proteins) and phospholipases. , 1997, European journal of biochemistry.

[38]  R. Jope,et al.  Phosphoinositide signaling in human brain , 1996, Progress in Neurobiology.

[39]  E. A. van der Veen,et al.  Effect of dietary cod-liver oil on the lipid composition of human erythrocyte membranes. , 1984, Scandinavian journal of clinical and laboratory investigation.

[40]  Shih-Yi Huang,et al.  Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial , 2003, European Neuropsychopharmacology.

[41]  M. Freeman.  Omega-3 Fatty Acids in Psychiatry: A Review , 2000, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[42]  In Kyoon Lyoo,et al.  Brain metabolic alterations in medication-free patients with bipolar disorder. , 2004, Archives of general psychiatry.

[43]  S. Rapoport,et al.  Identification of Two Molecular Species of Rat Brain Phosphatidylcholine that Rapidly Incorporate and Turn Over Arachidonic Acid In Vivo , 1996, Journal of neurochemistry.

[44]  Michael Rickels,et al.  Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants , 1995, Psychopharmacology.

[45]  R. Duman.  Depression: a case of neuronal life and death? , 2004, Biological Psychiatry.

[46]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[47]  M. Fava,et al.  Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine. , 1999, The American journal of psychiatry.

[48]  Stephan Heckers,et al.  Molecular evidence for mitochondrial dysfunction in bipolar disorder. , 2004, Archives of general psychiatry.

[49]  P. Fonlupt,et al.  Effects of cytidine-5' diphosphocholine on norepinephrine, dopamine and serotonin synthesis in various regions of the rat brain. , 1979, Archives internationales de pharmacodynamie et de therapie.

[50]  L. Marangell,et al.  A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. , 2003, The American journal of psychiatry.

[51]  A. Stoll,et al.  Omega 3 Fatty Acids in Bipolar Disorder A Preliminary Double-blind, Placebo-Controlled Trial , 1999 .

[52]  E. Nestler.  Antidepressant treatments in the 21st century , 1998, Biological Psychiatry.

[53]  E. Vartiainen,et al.  Fish consumption and depressive symptoms in the general population in Finland. , 2001, Psychiatric services.

[54]  W. Lands,et al.  Biochemistry and physiology of n‐3 fatty acids , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  D. Horrobin,et al.  Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. , 1998, Journal of affective disorders.

[56]  C. L. Jensen,et al.  Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. , 2003, American journal of obstetrics and gynecology.

[57]  R. Belmaker,et al.  Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. , 2002, The American journal of psychiatry.